Rheocarna treatment for non‐dialysis patients

The ulcers healed despite the removal rate of low-density lipoprotein and fibrinogen being small. To our knowledge, this is the first report on the treatment conditions and effectiveness of Rheocarna in non-dialysis patients.

Authors

Institutions

Publication Details

Journal
Therapeutic Apheresis and Dialysis
Published
2025-04-14
DOI
https://doi.org/10.1111/1744-9987.70024
Primary Topic
Peripheral Artery Disease Management
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Rheocarna treatment for non‐dialysis patients

Yuki Hoshikawa, Shotaro Naito, Takatoshi Sakurasawa, Soichiro Iimori et al.
Therapeutic Apheresis and Dialysis
Peripheral Artery Disease Management
article

Rheocarna treatment for non‐dialysis patients

Yuki Hoshikawa, Shotaro Naito, Takatoshi Sakurasawa, Soichiro Iimori, Naoki Kurashima, Shigeto Komori, Hiroshi Seshima, Ayako Itagaki, Mana Usui, Hiroko Yamamoto, Masaya Deushi, Atsushi Ohkubo
article en

Abstract

The ulcers healed despite the removal rate of low-density lipoprotein and fibrinogen being small. To our knowledge, this is the first report on the treatment conditions and effectiveness of Rheocarna in non-dialysis patients.

Therapeutic Apheresis and DialysisVol. 29(4)
Tokyo Medical University Hospital (JP), Institute of Science Tokyo (JP)
Good health and well-being
Openalex Percentile: Top 87%
Peripheral Artery Disease Management
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.